Results 71 to 80 of about 173,777 (119)

The Microbiome in Glioblastoma: Mechanisms, Tumor-Immune Interactions, and Translational Perspectives. [PDF]

Microbiologyopen
AlRamadneh TN, Jyothi-S R, Priyadarshini-Nayak P, Nanda A, Al-Hasnaawei S, Bhatt A, Singh-Chauhan A, Singla S, Mishra MK.   +8 more
europepmc   +1 more source

Cucurbitacin B suppresses GBM progression by inducing GADD45α-Dependent PCNA downregulation and DNA replication arrest. [PDF]

Front Pharmacol
Xue Y, Wang B.
europepmc   +1 more source

Design of a Six Degrees of Freedom Force/Torque Platform

Measurement + Control, 1991
J P Micallef, C Valentin, I Tadjou, R Quatrefages, P Arfos   +4 more
doaj   +1 more source

Functional divergence of the synapsin family in glioblastoma: Synapsin III as a candidate differentiation-restoring node. [PDF]

Front Neurol
Dai X, Ji Y, Cai Z, Zeng H, Li Y, Zhou H, Zhang X, Li B.   +7 more
europepmc   +1 more source

Tumor-associated macrophages in glioblastoma: implications for immunotherapy. [PDF]

Front Immunol
Lei J, Lao M, Ni Z, Chai W, Fang M, Wen Z, Lv X, Gao Y, Hu K.   +8 more
europepmc   +1 more source

Clinical-scale manufacturing of CD137+ enriched tumor-reactive T cells for glioblastoma in the CliniMACS Prodigy. [PDF]

Front Immunol
Riabinska A, Criado-Moronati E, Balta E, Frison D, Berganza-Irusqueta C, Telatar T, Maciaczyk D, Engeln J, Fischer L, Domdey M, Siddiqui I, Miranda V, Schmidt T, Kebir S, Ahmadipour Y, Glas M, Herrlinger U, Schneider M, Potthoff AL, Czabanka M, Broggini T, Stenqvist S, Nilsson LM, Nilsson JA, Ott M, Dzionek A, Hardy IR.   +26 more
europepmc   +1 more source

The Expression and Oncogenic Role of NTSR2 in Human Glioblastoma. [PDF]

Onco Targets Ther
Ouyang Q, Yang Y, Huang Z, Wang L, Ma Y, Yang Y.   +5 more
europepmc   +1 more source

A State-Resolved Single-Cell and Spatial Atlas Reveals <i>IDH</i>-Associated Differences in Malignant and Immune Architecture in Diffuse Glioma. [PDF]

MedComm (2020)
Zaman A, Holton E, Pandya M, Shillington G, Escher C, Sudhakar KK, Tuzesi A, Mehta A, Lam E, Zekanovic R, Sughrue M, Teo C, Yeung J, Muskovic W, Powell JE.   +14 more
europepmc   +1 more source

Phase Ia Evaluation of LP-184 in Recurrent Glioblastoma: Safety, Pharmacokinetics, and Translational Optimization of CNS Exposure. [PDF]

Cancer Res Commun
Schreck KC, Lal B, Zhou J, Lopez-Bertoni H, Holdhoff M, Ewesuedo R, Bhatia K, Chamberlain M, Laterra J.   +8 more
europepmc   +1 more source